Executive record

Thomas A. Fitzgerald, M.B.A.

Most recent record: TransCode Therapeutics, Inc. names John Tattory interim CFO (named as the outgoing officer), effective September 9, 2026. See TransCode Therapeutics, Inc..

1 verified record

2026-09-11 · Interim

TransCode Therapeutics, Inc. names John Tattory interim CFO

This page lists only verified filing records that name Thomas A. Fitzgerald, M.B.A.; it is not a career history. Corrections: the corrections page.